NCT07778446 A Study to Test CRT-402 in Refractory Autoimmune Disease Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07775235 Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease Status RECRUITING Phase N/A
NCT07668505 Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies Status NOT_YET_RECRUITING Phase PHASE4
NCT06991114 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. Status RECRUITING Phase PHASE2
NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease Status RECRUITING Phase PHASE1
NCT05979441 A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05895786 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Status RECRUITING Phase PHASE3
NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. Status COMPLETED Phase PHASE2/PHASE3
NCT05379634 A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies Status ACTIVE_NOT_RECRUITING Phase PHASE2